Celldex Therapeutics, Inc. (CLDX)
39.47
+0.23
(+0.59%)
USD |
NASDAQ |
Sep 02, 16:00
39.47
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics Shareholders Equity (Quarterly) : 714.56M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 714.56M |
| March 31, 2026 | 456.23M |
| December 31, 2025 | 527.16M |
| September 30, 2025 | 598.36M |
| June 30, 2025 | 655.41M |
| March 31, 2025 | 702.98M |
| December 31, 2024 | 747.00M |
| September 30, 2024 | 785.90M |
| June 30, 2024 | 813.66M |
| March 31, 2024 | 838.61M |
| December 31, 2023 | 429.17M |
| September 30, 2023 | 246.72M |
| June 30, 2023 | 277.54M |
| March 31, 2023 | 302.74M |
| December 31, 2022 | 326.20M |
| September 30, 2022 | 345.42M |
| June 30, 2022 | 365.09M |
| March 31, 2022 | 398.10M |
| December 31, 2021 | 419.48M |
| September 30, 2021 | 436.71M |
| June 30, 2021 | 182.28M |
| March 31, 2021 | 194.17M |
| December 31, 2020 | 209.36M |
| September 30, 2020 | 229.98M |
| June 30, 2020 | 238.44M |
| Date | Value |
|---|---|
| March 31, 2020 | 83.70M |
| December 31, 2019 | 94.03M |
| September 30, 2019 | 101.38M |
| June 30, 2019 | 109.63M |
| March 31, 2019 | 112.69M |
| December 31, 2018 | 124.06M |
| September 30, 2018 | 128.13M |
| June 30, 2018 | 128.05M |
| March 31, 2018 | 134.08M |
| December 31, 2017 | 236.37M |
| September 30, 2017 | 219.15M |
| June 30, 2017 | 231.46M |
| March 31, 2017 | 247.84M |
| December 31, 2016 | 265.43M |
| September 30, 2016 | 217.09M |
| June 30, 2016 | 234.71M |
| March 31, 2016 | 260.03M |
| December 31, 2015 | 290.10M |
| September 30, 2015 | 318.63M |
| June 30, 2015 | 345.88M |
| March 31, 2015 | 375.55M |
| December 31, 2014 | 211.66M |
| September 30, 2014 | 239.37M |
| June 30, 2014 | 265.32M |
| March 31, 2014 | 291.85M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 11.83B |
| Ionis Pharmaceuticals, Inc. | 439.74M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 782.35M |
| Total Liabilities (Quarterly) | 67.78M |
| Debt to Equity Ratio | 0.0069 |
| Current Ratio | 11.82 |
| Net Debt Paydown Yield | -0.01% |